A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.
NCT ID: NCT00035542
Last Updated: 2011-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
INTERVENTIONAL
2001-12-31
2003-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes
NCT00035568
Metabolic Effect of Metformin in Obese Insulin Resistant Adolescents With Normal Glucose Tolerance
NCT00667498
A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate
NCT00740051
Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes
NCT00622284
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
NCT01541215
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Glucovance (metformin HCl/glyburide)
metformin HCl
glyburide
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
9 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bristol-Myers Squibb
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Childrens's Health System/Dept of PED/Diabetes/Endoncrinology
Birmingham, Alabama, United States
Advanced Clinical Therapeutics
Tucson, Arizona, United States
Hazan, Lydie
Beverly Hills, California, United States
Bautista Research & Medical Center
Fresno, California, United States
Health Care Link, Inc
La Jolla, California, United States
Neufeld Medical Group
Los Angeles, California, United States
National Institute Of Clinical Research
Los Angeles, California, United States
Pasadena Pediatric Endocrinology Diabetes
Pasadena, California, United States
A.R.I. Clinical Trials
Redondo Beach, California, United States
Sutter Institute For Medical Research
Sacramento, California, United States
Children's Hospital
Denver, Colorado, United States
Connecticut Children's Medical Center
Hartford, Connecticut, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
EDU Practice Pediatric Endocrinology
Tallahassee, Florida, United States
Southeastern Endocrine and Diabetes
Atlanta, Georgia, United States
University of Hawaii/Diabetes Research Group
‘Ewa Beach, Hawaii, United States
St. James Diabetes Center
Chicago Heights, Illinois, United States
Lutheran General Children's Hospital
Park Ridge, Illinois, United States
Raymond Blank Children's Hospital
Des Moines, Iowa, United States
Louisville Metabolic & Athersclerosis Research Center/Advanced Cardiovascular Institute
Louisville, Kentucky, United States
Bay East Endocrinologists
Easton, Maryland, United States
Joslin Diabetes Center
Boston, Massachusetts, United States
JM Clinical Trials Inc
Swansea, Massachusetts, United States
Center for Health Management
Gulfport, Mississippi, United States
Medex Healthcare Research
St Louis, Missouri, United States
Diabetes, Endocrine & Nutrition Core Physicians
Hampton, New Hampshire, United States
Hackensack Medical Center
Hackensack, New Jersey, United States
Endocrine & Diabetes Center
Jersey City, New Jersey, United States
SUNY Downstate Medical Center / Dept of Endocrinology
Brooklyn, New York, United States
Children's Hospital of Buffalo/Kaledia Health Diabetes Center
Buffalo, New York, United States
Winthrop University Hospital, Clinical Trials Center
Mineola, New York, United States
St Luke's Roosevelt Hospital/Westside Pediatrics Assoc/Clinical Pharmacology Program
New York, New York, United States
Vassar Brothers Hospital
Poughkeepsie, New York, United States
University of Rochester/Dpt Pediatrics, S.M.H.
Rochester, New York, United States
Montefioe Medical Center - DIV / c/o BRANY
The Bronx, New York, United States
East Carolina University School of Medicine Dept of Pediatrics
Greenville, North Carolina, United States
Children's Hospital Medical Center of Akron
Akron, Ohio, United States
Metro Health Medical Center
Cleveland, Ohio, United States
The Cleveland Clinic Children's Hospital/Dept of Pediatrics
Cleveland, Ohio, United States
Forum Health/Western Reserve/TOD Children's Hospital
Youngstown, Ohio, United States
Greenville Hospital System/Mountain View Clinical Research/Div of Pediatric Endocrinology
Greenville, South Carolina, United States
Lebonheur Children's Medical Center
Memphis, Tennessee, United States
South Texas Applied Research
Corpus Christi, Texas, United States
Driscoll Children's Hospital/Division of Medical Education/William Riley
Corpus Christi, Texas, United States
Tri Quest Research Inc
Houston, Texas, United States
Wilford Hall USAF Medical Center
Lackland Air Force Base, Texas, United States
Lance Sloan, MD
Lufkin, Texas, United States
Diabetes & Glandular Disease Clinic
San Antonio, Texas, United States
S.A.M. Clinical Research Center
San Antonio, Texas, United States
Monarch Research Associates
Norfolk, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CV138-059
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.